In this study, we investigated the short-term effect of 17β-oestradiol on functional enzyme activity (FEA) of endothelin-converting enzymes in vitro using human internal mammary arteries (n = 7–8) and human saphenous veins (n = 16–17) obtained from patients undergoing coronary artery bypass graft surgery. Vascular rings were preincubated with either solvent control (0.2% ethanol) or 17β-oestradiol (1µM) for 30min and concentration–response curves to big ET-1 (0.1–100nM) or ET-1 (0.1–100nM) were performed. FEA for each concentration was calculated as the percentage activity [(contraction to big ET-1/contraction to ET-1)×100] normalized to KCl (100mM). In control experiments, at low concentrations FEA was lower in internal mammary arteries than in saphenous veins (P<0.05). While FEA was suppressed in saphenous veins by 10nM (4±1 versus 22±5%, P<0.01) and 30nM (26±4 versus 48±7%, P<0.05) 17β-oestradiol, FEA was markedly enhanced in internal mammary arteries by 10nM (33±12 versus 1±1%, P<0.001) and 30nM (44±12 versus 8±3%, P<0.01) 17β-oestradiol . FEA was not affected by 100nM 17β-oestradiol. These results demonstrate for the first time that short-term exposure to 17β-oestradiol affects FEA in vitro. Human internal mammary arteries have lower FEA than the saphenous veins, but FEA is differentially affected by acute exposure to 17β-oestradiol in human arteries and veins. Whether changes in FEA play a role in the vascular effects of 17β-oestradiol in vivo remains to be determined.
Skip Nav Destination
Article navigation
September 2002
-
Cover Image
Cover Image
Conference Article|
September 01 2002
Acute effects of 17 β-oestradiol on functional activity of endothelin-converting enzymes in human arteries and veins
Andres HEIGL;
Andres HEIGL
*Medical Policlinic, Department of Internal Medicine, University Hospital, Rämistrasse 100, CH-8091 Zürich, Switzerland
†Clinical Atherosclerosis Research Laboratory, Medical Policlinic, Department of Internal Medicine, University Hospital, Rämistrasse 100, CH-8091 Zürich, Switzerland
Search for other works by this author on:
Mario LACHAT;
Mario LACHAT
‡Department of Cardiac Surgery, University Hospital, Rämistrasse 100, CH-8091 Zürich, Switzerland
Search for other works by this author on:
Thomas LATTMANN;
Thomas LATTMANN
†Clinical Atherosclerosis Research Laboratory, Medical Policlinic, Department of Internal Medicine, University Hospital, Rämistrasse 100, CH-8091 Zürich, Switzerland
Search for other works by this author on:
Thomas LÜSCHER;
Thomas LÜSCHER
§Division of Cardiology, Department of Internal Medicine, University Hospital, Rämistrasse 100, CH-8091 Zürich, Switzerland
Search for other works by this author on:
Matthias BARTON
*Medical Policlinic, Department of Internal Medicine, University Hospital, Rämistrasse 100, CH-8091 Zürich, Switzerland
†Clinical Atherosclerosis Research Laboratory, Medical Policlinic, Department of Internal Medicine, University Hospital, Rämistrasse 100, CH-8091 Zürich, Switzerland
Dr M. Barton at Department of Internal Medicine, Medical Policlinic, University Hospital, Rämistrasse 100, CH-8091 Zürich, Switzerland (e-mail [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 2002 The Biochemical Society and the Medical Research Society
2002
Clin Sci (Lond) (2002) 103 (s2002): 438S–441S.
Citation
Andres HEIGL, Mario LACHAT, Thomas LATTMANN, Thomas LÜSCHER, Matthias BARTON; Acute effects of 17 β-oestradiol on functional activity of endothelin-converting enzymes in human arteries and veins. Clin Sci (Lond) 1 September 2002; 103 (s2002): 438S–441S. doi: https://doi.org/10.1042/CS103S438S
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |